Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)

NCT05459753 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT05459753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 1, 2022
Completion date
June 30, 2027
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, progressive supranuclear palsy